Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2025 | SBRT as an emerging alternative treatment for primary kidney cancer

Giulio Francolini • 14 Feb 2025
GU Cancers 2025
Genitourinary Cancer Kidney Cancer

Giulio Francolini, MD, University of Florence, Florence, Italy, discusses the growing role of stereotactic body radiation therapy (SBRT) in primary kidney cancer and the importance of patient selection. Recent analysis suggests that patients with poor nephrometric scores, who are not ideal candidates for partial nephrectomy, may benefit from SBRT. These findings highlight SBRT as a potential alternative treatment for select patients. This interview took place at the ASCO GU Cancers Symposium 2025 in San Francisco, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Giulio Francolini

Exploring SBRT for patients with localized kidney tumors
0:48
Exploring SBRT for patients with localized kidney tumors
Giulio Francolini • 26 Feb 2026
ULTRA-HERO: radiotherapy & relugolix for intermediate risk prostate cancer
1:06
ULTRA-HERO: radiotherapy & relugolix for intermediate risk prostate cancer
Giulio Francolini • 26 Feb 2026
ARTO: long-term OS of SBRT and abiraterone in oligometastatic prostate cancer
0:48
ARTO: long-term OS of SBRT and abiraterone in oligometastatic prostate cancer
Giulio Francolini • 26 Feb 2026
PERSIAN: predictive features of complete biochemical response in prostate cancer
0:53
PERSIAN: predictive features of complete biochemical response in prostate cancer
Giulio Francolini • 26 Feb 2026

Related Videos

Current and emerging systemic strategies in biochemically relapsed prostate cancer
2:45
Current and emerging systemic strategies in biochemically relapsed prostate cancer
Ashwin Sachdeva • 16 May 2026
How has SABR improved radiotherapy practice in kidney cancer?
1:06
How has SABR improved radiotherapy practice in kidney cancer?
Shankar Siva • 16 May 2026
Which patients with kidney cancer may benefit from SABR treatment?
1:58
Which patients with kidney cancer may benefit from SABR treatment?
Shankar Siva • 16 May 2026
Management of brain metastasis in patients with poor-risk testicular cancer
1:03
Management of brain metastasis in patients with poor-risk testicular cancer
Darren Feldman • 30 May 2026
The content of VJOncology is intended for healthcare professionals